About this trial
This study aims to compare two different pain management methods in patients undergoing elective lumbar spine surgery. Patients are randomly assigned to receive either an ultrasound-guided erector spinae plane block (ESPB) or intravenous multimodal analgesia.
Postoperative pain will be assessed using both clinical pain scores and the Analgesia Nociception Index (ANI), a non-invasive monitoring system that evaluates pain-related responses based on heart rate variability. The goal of this study is to determine which method provides better postoperative pain control.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age between 18 and 65 years
ASA physical status I-II
Scheduled for elective lumbar spine surgery
Ability to provide informed consent
Disqualifiers
Known allergy to study medications
Coagulation disorders
Infection at the block site
Severe cardiovascular disease
Trial design
Parallel
Treatments tested in this trial
Erector Spinae Plane Block
Procedure/SurgeryUltrasound-guided bilateral erector spinae plane block performed at the thoracolumbar level using a total of 200 mg bupivacaine for postoperative analgesia.
Intravenous Multimodal Analgesia
DrugIntravenous administration of paracetamol 1 g, morphine 0.1 mg/kg, dexamethasone 8 mg, and ketamine 0.5 mg/kg bolus followed by 0.3 mg/kg/h infusion for postoperative pain management.
Treatment groups
Trial outcomes
Primary outcomes
Analgesia Nociception Index (ANI)
Analgesia Nociception Index (ANI) measured using the ANI monitor. The ANI ranges from 0 to 100. Higher values indicate greater parasympathetic tone and lower nociceptive stimulation, whereas lower values indicate higher nociceptive stimulation.
Secondary outcomes
Visual Analog Scale (VAS) Pain Score
Pain intensity assessed using the Visual Analog Scale (VAS), ranging from 0 (no pain) to 10 (worst imaginable pain). Higher scores indicate worse pain.
Postoperative Nausea
Incidence of postoperative nausea within 24 hours after surgery.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.